NO20032439L - Laktamforbindelser og farmasöytisk anvendelse derav - Google Patents

Laktamforbindelser og farmasöytisk anvendelse derav

Info

Publication number
NO20032439L
NO20032439L NO20032439A NO20032439A NO20032439L NO 20032439 L NO20032439 L NO 20032439L NO 20032439 A NO20032439 A NO 20032439A NO 20032439 A NO20032439 A NO 20032439A NO 20032439 L NO20032439 L NO 20032439L
Authority
NO
Norway
Prior art keywords
diabetic
pharmaceutical use
lactam compounds
agent
adiposis
Prior art date
Application number
NO20032439A
Other languages
English (en)
Other versions
NO325401B1 (no
NO20032439D0 (no
Inventor
Yukio Iino
Takao Ikenoue
Nobuo Kondo
Hiroyuki Matsueda
Toshihiro Hatanaka
Ryusuke Hirama
Yoko Masuzawa
Fumio Ohta
Akiyo Yamazaki
Original Assignee
Ajinomoto Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Kk filed Critical Ajinomoto Kk
Publication of NO20032439D0 publication Critical patent/NO20032439D0/no
Publication of NO20032439L publication Critical patent/NO20032439L/no
Publication of NO325401B1 publication Critical patent/NO325401B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyrrole Compounds (AREA)
NO20032439A 2000-12-01 2003-05-28 Laktamforbindelser, anvendelse av slike samt farmasoytisk preparat inneholdende nevnte laktamforbindelser NO325401B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000367175 2000-12-01
PCT/JP2001/010435 WO2002044180A1 (en) 2000-12-01 2001-11-29 Lactam compounds and medicinal use thereof

Publications (3)

Publication Number Publication Date
NO20032439D0 NO20032439D0 (no) 2003-05-28
NO20032439L true NO20032439L (no) 2003-07-18
NO325401B1 NO325401B1 (no) 2008-04-21

Family

ID=18837660

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032439A NO325401B1 (no) 2000-12-01 2003-05-28 Laktamforbindelser, anvendelse av slike samt farmasoytisk preparat inneholdende nevnte laktamforbindelser

Country Status (26)

Country Link
US (3) US7153850B2 (no)
EP (1) EP1346993B1 (no)
JP (2) JP3826400B2 (no)
KR (1) KR100826818B1 (no)
CN (2) CN100577651C (no)
AT (1) ATE446297T1 (no)
AU (3) AU1850202A (no)
BG (1) BG107857A (no)
BR (1) BR0115852A (no)
CA (1) CA2430124C (no)
CZ (1) CZ20031520A3 (no)
DE (1) DE60140270D1 (no)
ES (1) ES2331299T3 (no)
HU (1) HUP0400806A3 (no)
IL (1) IL156158A0 (no)
MX (1) MXPA03004876A (no)
NO (1) NO325401B1 (no)
NZ (1) NZ526164A (no)
PL (1) PL362835A1 (no)
RU (1) RU2287530C2 (no)
SK (1) SK6582003A3 (no)
TW (1) TWI241302B (no)
UA (1) UA76969C2 (no)
WO (1) WO2002044180A1 (no)
YU (1) YU42603A (no)
ZA (1) ZA200304100B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL362835A1 (en) * 2000-12-01 2004-11-02 Ajinomoto Co,Inc. Lactam compounds and medicinal use thereof
CN1771040B (zh) * 2003-02-07 2010-06-16 味之素株式会社 糖尿病治疗药
CA2544310A1 (en) 2003-10-31 2005-05-12 Ajinomoto Co., Inc. New fused polycyclic compounds having a heterocyclic ring(s) and pharmaceutical use thereof
JPWO2005068467A1 (ja) 2004-01-14 2007-12-27 味の素株式会社 新規縮環化合物
KR100858262B1 (ko) * 2004-10-13 2008-09-11 에프. 호프만-라 로슈 아게 Ｃｄｋ2 및 혈관신생에 대한 저해제로서 유용하고, 유방암,대장암, 폐암 및 전립선암의 치료용으로 유용한이중치환된 피라졸로벤조디아제핀
NZ563131A (en) 2005-04-28 2010-09-30 Ajinomoto Kk Tricyclic lactam compound as a hypoglycemic agent
EP2157092A4 (en) * 2007-04-11 2011-04-13 Ajinomoto Kk Remedy for diabetes
WO2008139575A1 (ja) * 2007-04-27 2008-11-20 Ajinomoto Co., Inc. 経口投与用製剤
WO2008139574A1 (ja) * 2007-04-27 2008-11-20 Ajinomoto Co., Inc. ラクタム化合物の結晶形およびその製造方法
WO2008136392A1 (ja) * 2007-04-27 2008-11-13 Ajinomoto Co., Inc. 経口投与用製剤
CN101619041B (zh) * 2008-07-02 2012-07-04 重庆华邦制药股份有限公司 一种二酮基含氮环化合物的合成方法及其中间体
JP2012180282A (ja) * 2009-07-02 2012-09-20 Ajinomoto Co Inc ラクタム化合物の製造方法およびその製造中間体
JP2012180283A (ja) * 2009-07-02 2012-09-20 Ajinomoto Co Inc ラクタム化合物の製造方法およびその製造中間体
RU2017126027A (ru) * 2014-12-22 2019-01-24 ЕА Фарма Ко., Лтд. Лекарственное средство для лечения расстройств эпителия роговицы
CA3011538A1 (en) 2016-01-18 2017-07-27 Arisan Therapeutics Adamantane derivatives for the treatment of filovirus infection
WO2019018185A1 (en) 2017-07-15 2019-01-24 Arisan Therapeutics Inc. ENANTIOMERICALLY PURE ADAMATANE DERIVATIVES FOR THE TREATMENT OF FILOVIRUS INFECTIONS
JP7566338B2 (ja) * 2019-01-23 2024-10-15 ▲たん▼解生醫股分有限公司 グルコース代謝障害の長時間作用型の予防または治療に使用するためのβ－ラクタム化合物またはその塩

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US189597A (en) * 1877-04-17 Improvement in portable wash-stands
US48847A (en) * 1865-07-18 Improvement in vessels for reception and transportation of night-soil
GB8720414D0 (en) * 1987-08-28 1987-10-07 Roussel Lab Ltd Chemical compounds
US5719296A (en) * 1995-10-30 1998-02-17 Merck & Co., Inc. Pseudopeptide lactam inhibitors of peptide binding to MHC class II proteins
AU8592598A (en) 1997-07-30 1999-02-22 Wyeth Tricyclic vasopressin agonists
JP4204657B2 (ja) 1997-12-05 2009-01-07 有限会社ケムフィズ 糖尿病の予防・治療剤
PL362835A1 (en) * 2000-12-01 2004-11-02 Ajinomoto Co,Inc. Lactam compounds and medicinal use thereof
CN1771040B (zh) * 2003-02-07 2010-06-16 味之素株式会社 糖尿病治疗药

Also Published As

Publication number Publication date
YU42603A (sh) 2006-03-03
US7632830B2 (en) 2009-12-15
KR20030051893A (ko) 2003-06-25
ZA200304100B (en) 2004-08-22
EP1346993A4 (en) 2005-12-21
US7153850B2 (en) 2006-12-26
RU2287530C2 (ru) 2006-11-20
CA2430124A1 (en) 2002-06-06
JP2006213732A (ja) 2006-08-17
BR0115852A (pt) 2003-12-23
HUP0400806A3 (en) 2007-11-28
AU2006241377A1 (en) 2006-12-14
BG107857A (bg) 2004-06-30
ES2331299T3 (es) 2009-12-29
DE60140270D1 (de) 2009-12-03
WO2002044180A1 (en) 2002-06-06
NO325401B1 (no) 2008-04-21
HUP0400806A2 (hu) 2004-07-28
JPWO2002044180A1 (ja) 2004-04-02
ATE446297T1 (de) 2009-11-15
EP1346993B1 (en) 2009-10-21
US20080096862A1 (en) 2008-04-24
CN100577651C (zh) 2010-01-06
UA76969C2 (en) 2006-10-16
TWI241302B (en) 2005-10-11
CN1269818C (zh) 2006-08-16
NZ526164A (en) 2004-09-24
US20040048847A1 (en) 2004-03-11
CN1487940A (zh) 2004-04-07
US7326701B2 (en) 2008-02-05
AU2006241377B2 (en) 2009-01-08
IL156158A0 (en) 2003-12-23
JP4505753B2 (ja) 2010-07-21
SK6582003A3 (en) 2003-09-11
PL362835A1 (en) 2004-11-02
MXPA03004876A (es) 2004-01-27
JP3826400B2 (ja) 2006-09-27
CN1911915A (zh) 2007-02-14
CZ20031520A3 (cs) 2003-10-15
EP1346993A1 (en) 2003-09-24
CA2430124C (en) 2011-01-11
NO20032439D0 (no) 2003-05-28
KR100826818B1 (ko) 2008-05-02
US20060189597A1 (en) 2006-08-24
AU2002218502B2 (en) 2006-09-21
AU1850202A (en) 2002-06-11

Similar Documents

Publication Publication Date Title
NO20032439L (no) Laktamforbindelser og farmasöytisk anvendelse derav
NO20013469L (no) Fremgangsmåter for glukagonsuppresjon
TWI328576B (en) Diketohydrazine derivative compound, medicament containing same as active ingredient
DE60118885D1 (de) Nitratsalze von antimikrobiellen wirkstoffen
EP1308168A4 (en) NEW MEDICINES FOR CANCER
SE9903759D0 (sv) Pharmaceutically active compounds
HUP0400155A3 (en) N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same
DE59907481D1 (de) Kontrolliert freisetzende pharmazeutische zusammensetzung mit tilidinmesylat als wirkstoff
DE59910758D1 (de) Transdermales pflaster, enthaltend mindestens einen die blutfettwerte beeinflussenden wirkstoff
WO2003082926A3 (en) Antimicrobial polymer conjugates
MXPA02001575A (es) Agente farmaceutico que comprende un derivado de benzamida como un ingrediente activo.
ZA200304928B (en) Medicament containing a polyamine as an active substance.
NO985571L (no) Legemiddel for autoimmunsykdommer
SI1197223T1 (no)
TW200509980A (en) Parasiticidal composition
WO2003011247A3 (de) Trägermatrix mit wirkstoffbeladenen partikeln zur anwendung auf der haut oder schleimhaut
DE69941897D1 (de) Arzneimittel für nicht-cardiogene diastolische dysfunktion
IT1317841B1 (it) Derivati del 3,9-diazabiciclo(3.3.1)nonano ad attivita' analgesica.
FR2885807A1 (fr) Composition pharmaceutique solide a liberation prolongee de 1-(2,3,4-trimethoxybenzyl) piperazine, et procede de preparation
ATE285236T1 (de) Antivirale zusammensetzungen enthaltend yohimbin als therapeutischen wirkstoff
NO20041878L (no) Karboksylsyrederivat-forbindelser og legemidler inneholdende de samme som den aktive bestanddel.
WO2002024210A3 (en) Halogen compounds for use in medicine
ZA200202426B (en) Pyrimidine derivatives, process for preparing the derivatives and drugs containing the same as the active ingredient.
DE60233647D1 (de) Reduziertes vitamin b2 enthaltende arzneimittel
DE60008536D1 (de) Topische antiseptische zusammensetzung

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees